Terms: = Kidney tumors AND TRB
3 results:
1. trb CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Hudock TR; Barker VR; Manley BJ; Chobrutskiy A; Chobrutskiy BI; Diaz MJ; Song JJ; Blanck G
Cancer Biomark; 2023; 38(1):103-110. PubMed ID: 37545223
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
[TBL] [Abstract] [Full Text] [Related]
3. Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.
Cherukuri A; Rothstein DM; Clark B; Carter CR; Davison A; Hernandez-Fuentes M; Hewitt E; Salama AD; Baker RJ
J Am Soc Nephrol; 2014 Jul; 25(7):1575-85. PubMed ID: 24610932
[TBL] [Abstract] [Full Text] [Related]
